Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results
D Orlic, E Bonizzoni, G Stankovic, F Airoldi… - Journal of the American …, 2004 - jacc.org
Objectives: This study evaluated clinical outcome after multivessel stenting with sirolimus-
eluting stents (SES) in unselected lesions. Background: Safety and effectiveness of …
eluting stents (SES) in unselected lesions. Background: Safety and effectiveness of …
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo …
Objectives: The purpose of this study is to compare the 5-year clinical outcomes, safety, and
efficacy of sirolimus-eluting stents (SES) in the ARTS II (Arterial Revascularization Therapies …
efficacy of sirolimus-eluting stents (SES) in the ARTS II (Arterial Revascularization Therapies …
[PDF][PDF] Arterial Revascularisation Therapies Study Part II-Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.
PW Serruys, AT Ong, MC Morice… - The Unrestricted Use …, 2005 - repub.eur.nl
Aim: To determine the safety and effectiveness of CYPHER® sirolimus-eluting stent
implantation in patients with multivessel disease; and to compare outcomes against the …
implantation in patients with multivessel disease; and to compare outcomes against the …
Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)
PW Serruys, PA Lemos, BA Van Hout - Heart, 2004 - heart.bmj.com
Objectives The main goal of the ARTS II trial is to assess a noninferiority of sirolimus eluting
stent implantation for patients with multivessel disease with respect to the previous result of …
stent implantation for patients with multivessel disease with respect to the previous result of …
Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention
WW Chu, PK Kuchulakanti, SW Rha… - The American journal of …, 2006 - Elsevier
This retrospective analysis compared clinical outcomes of patients who underwent stenting
with≥ 3 sirolimus-eluting stents (SESs) with those who received a single SES. SES …
with≥ 3 sirolimus-eluting stents (SESs) with those who received a single SES. SES …
Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents …
M Valgimigli, K Dawkins, C Macaya… - Journal of the American …, 2007 - jacc.org
Objectives: We sought to evaluate the impact of unstable coronary artery disease (CAD) on
short-and mid-term outcomes in patients with multivessel disease treated by multiple …
short-and mid-term outcomes in patients with multivessel disease treated by multiple …
Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries …
H Kelbæk, L Kløvgaard, S Helqvist, JF Lassen… - Journal of the American …, 2008 - jacc.org
Objectives: Our purpose was to evaluate the long-term use of sirolimus-eluting stents (SES)
and bare-metal stents (BMS) in patients with complex coronary artery lesions. Background …
and bare-metal stents (BMS) in patients with complex coronary artery lesions. Background …
Elective sirolimus‐eluting stent implantation for multivessel disease involving significant LAD stenosis: One‐year clinical outcomes of 99 consecutive patients—the …
The aim of this study was to evaluate the effectiveness of sirolimus‐eluting stent (SES)
implantation for patients with multivessel disease, which included left anterior descending …
implantation for patients with multivessel disease, which included left anterior descending …
Very long sirolimus-eluting stent implantation for de novo coronary lesions
M Degertekin, CA Arampatzis, PA Lemos, F Saia… - The American journal of …, 2004 - Elsevier
Long-length stenting has a poor outcome when bare metal stents are used. The safety and
efficacy of the sirolimus-eluting stent (SES) in long lesions has not been evaluated …
efficacy of the sirolimus-eluting stent (SES) in long lesions has not been evaluated …
Five-year follow-up after sirolimus-eluting stent implantation: results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trial
G Weisz, MB Leon, DR Holmes, DJ Kereiakes… - Journal of the American …, 2009 - jacc.org
Objectives: The aim of this study was to examine the 5-year clinical safety and efficacy
outcomes in patients enrolled in the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native …
outcomes in patients enrolled in the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native …